Khosrovi Behzad 4/A
4/A · NovaBay Pharmaceuticals, Inc. · Filed Nov 15, 2010
Insider Transaction Report
Form 4/AAmended
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2009-01-28+21,300→ 294,200 totalExercise: $1.56From: 2010-01-28Exp: 2019-01-28→ Common Stock (21,300 underlying)
Footnotes (1)
- [F1]Original Form 4 filed on February 12, 2009. This amended form is being filed to correct the total securities following reported transaction under Table II, Item 9 which should be 294,200 not 94,200.